Array
(
[id] => 1348
[catid] => 297
[title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1348.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:24:30
[updatetime] => 2024-01-11 15:24:30
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => Prophylactic administration of fibrinogen concentrate is not recommended in prostate surgery. (Evidence level: low;Recommendation grade:strong)
[laiyuan] => 在前列腺手术中不推荐预防性使用纤维蛋白原浓缩物。(证据级别:低;推荐强度:强推荐)
[znzldj] => B
[_inputtime] => 1704957870
[_updatetime] => 1704957870
[_nrjc] =>
[_nrsh] =>
)
推荐意见
在前列腺手术中不推荐预防性使用纤维蛋白原浓缩物。(证据级别:低;推荐强度:强推荐)
Prophylactic administration of fibrinogen concentrate is not recommended in prostate surgery. (Evidence level: low;Recommendation grade:strong)
证据评价方法:GRADE
指南质量等级:B
年份:2023
国家:the European Society of Anaesthesiology and Intens
Array
(
[id] => 1349
[catid] => 297
[title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1349.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:24:30
[updatetime] => 2024-01-11 15:24:30
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => Computed tomography scan or angiography are suggested for the diagnosis of late bleeding after pancreatectomy, and endovascular interventional therapy is suggested as primary treatment. (Evidence level: low;Recommendation grade:weak)
[laiyuan] => 胰腺切除术后迟发性出血的诊断建议行CT或血管造影检查,血管内介入治疗为首选治疗方法。(证据级别:低;推荐强度:弱推荐)
[znzldj] => B
[_inputtime] => 1704957870
[_updatetime] => 1704957870
[_nrjc] =>
[_nrsh] =>
)
推荐意见
胰腺切除术后迟发性出血的诊断建议行CT或血管造影检查,血管内介入治疗为首选治疗方法。(证据级别:低;推荐强度:弱推荐)
Computed tomography scan or angiography are suggested for the diagnosis of late bleeding after pancreatectomy, and endovascular interventional therapy is suggested as primary treatment. (Evidence level: low;Recommendation grade:weak)
证据评价方法:GRADE
指南质量等级:B
年份:2023
国家:the European Society of Anaesthesiology and Intens
Array
(
[id] => 1350
[catid] => 297
[title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1350.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:24:30
[updatetime] => 2024-01-11 15:24:30
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => Preoperative chronic antithrombotic therapy and perioperative chemical thromboprophylaxis seem not to increase the peri-operative haemorrhagic complications in patients undergoing HPB surgery. (Evidence level: low)
[laiyuan] => 术前长期抗栓治疗和围手术期预防性化学血栓治疗不会增加HPB患者围手术期出血并发症的发生。(证据级别:低)
[znzldj] => B
[_inputtime] => 1704957870
[_updatetime] => 1704957870
[_nrjc] =>
[_nrsh] =>
)
推荐意见
术前长期抗栓治疗和围手术期预防性化学血栓治疗不会增加HPB患者围手术期出血并发症的发生。(证据级别:低)
Preoperative chronic antithrombotic therapy and perioperative chemical thromboprophylaxis seem not to increase the peri-operative haemorrhagic complications in patients undergoing HPB surgery. (Evidence level: low)
证据评价方法:GRADE
指南质量等级:B
年份:2023
国家:the European Society of Anaesthesiology and Intens
Array
(
[id] => 1351
[catid] => 297
[title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1351.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:24:30
[updatetime] => 2024-01-11 15:24:30
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => We suggest that cell salvage is not contraindicated in cancer surgery, provided that blood aspiration close to the tumour site is avoided and leukodepletion filters are used. (Evidence level: low;Recommendation grade:weak)
[laiyuan] => 我们认为,在肿瘤手术中,只要避免靠近肿瘤部位的血液抽吸,并使用白细胞清除滤器,细胞回收并不禁忌。(证据级别:低;推荐强度:弱推荐)
[znzldj] => B
[_inputtime] => 1704957870
[_updatetime] => 1704957870
[_nrjc] =>
[_nrsh] =>
)
推荐意见
我们认为,在肿瘤手术中,只要避免靠近肿瘤部位的血液抽吸,并使用白细胞清除滤器,细胞回收并不禁忌。(证据级别:低;推荐强度:弱推荐)
We suggest that cell salvage is not contraindicated in cancer surgery, provided that blood aspiration close to the tumour site is avoided and leukodepletion filters are used. (Evidence level: low;Recommendation grade:weak)
证据评价方法:GRADE
指南质量等级:B
年份:2023
国家:the European Society of Anaesthesiology and Intens
Array
(
[id] => 1296
[catid] => 297
[title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1296.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:24:29
[updatetime] => 2024-01-11 15:24:29
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => Withdrawal of aspirin treatment before surgery might increase the risk of coronary thrombosis; however, continuation of aspirin treatment increases the risk of bleeding.(Evidence level: moderate)
[laiyuan] => 在手术前停止阿司匹林治疗可能会增加冠状动脉血栓形成的风险;然而,持续阿司匹林治疗会增加出血的风险。(证据级别:中)
[znzldj] => B
[_inputtime] => 1704957869
[_updatetime] => 1704957869
[_nrjc] =>
[_nrsh] =>
)
推荐意见
在手术前停止阿司匹林治疗可能会增加冠状动脉血栓形成的风险;然而,持续阿司匹林治疗会增加出血的风险。(证据级别:中)
Withdrawal of aspirin treatment before surgery might increase the risk of coronary thrombosis; however, continuation of aspirin treatment increases the risk of bleeding.(Evidence level: moderate)
证据评价方法:GRADE
指南质量等级:B
年份:2023
国家:the European Society of Anaesthesiology and Intens
Array
(
[id] => 1297
[catid] => 297
[title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1297.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:24:29
[updatetime] => 2024-01-11 15:24:29
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => Withdrawal of treatment with P2Y12 inhibitors (clopidogrel, prasugrel and ticagrelor) before surgery might increase the risk of coronary thrombosis; however, continuation of clopidogrel therapy increases the risk of bleeding.(Evidence level: moderate)
[laiyuan] => 术前停用P2Y12抑制剂(氯吡格雷、普拉格雷和替卡格雷)可能会增加冠状动脉血栓形成的风险;然而,继续氯吡格雷治疗会增加出血的风险。(证据级别:中)
[znzldj] => B
[_inputtime] => 1704957869
[_updatetime] => 1704957869
[_nrjc] =>
[_nrsh] =>
)
推荐意见
术前停用P2Y12抑制剂(氯吡格雷、普拉格雷和替卡格雷)可能会增加冠状动脉血栓形成的风险;然而,继续氯吡格雷治疗会增加出血的风险。(证据级别:中)
Withdrawal of treatment with P2Y12 inhibitors (clopidogrel, prasugrel and ticagrelor) before surgery might increase the risk of coronary thrombosis; however, continuation of clopidogrel therapy increases the risk of bleeding.(Evidence level: moderate)
证据评价方法:GRADE
指南质量等级:B
年份:2023
国家:the European Society of Anaesthesiology and Intens
Array
(
[id] => 1298
[catid] => 297
[title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1298.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:24:29
[updatetime] => 2024-01-11 15:24:29
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => In patients on DAPT who need to undergo nonemergency cardiac surgery, postponing surgery for at least 5 days after discontinuation of ticagrelor or clopidogrel and 7 days after prasugrel should be considered.(Evidence level: moderate;Recommendation grade: weak)
[laiyuan] => 对于需要进行非紧急心脏手术的双重抗血小板治疗患者,停用替格瑞洛或氯吡格雷后至少推迟5天,普拉格雷7天后考虑手术。(证据级别:中;推荐强度:弱推荐)
[znzldj] => B
[_inputtime] => 1704957869
[_updatetime] => 1704957869
[_nrjc] =>
[_nrsh] =>
)
推荐意见
对于需要进行非紧急心脏手术的双重抗血小板治疗患者,停用替格瑞洛或氯吡格雷后至少推迟5天,普拉格雷7天后考虑手术。(证据级别:中;推荐强度:弱推荐)
In patients on DAPT who need to undergo nonemergency cardiac surgery, postponing surgery for at least 5 days after discontinuation of ticagrelor or clopidogrel and 7 days after prasugrel should be considered.(Evidence level: moderate;Recommendation grade: weak)
证据评价方法:GRADE
指南质量等级:B
年份:2023
国家:the European Society of Anaesthesiology and Intens
Array
(
[id] => 1299
[catid] => 297
[title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1299.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:24:29
[updatetime] => 2024-01-11 15:24:29
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => Platelet function testing may be considered to guide the decision on the timing of cardiac surgery in patients who have recently received P2Y12 inhibitors.(Evidence level: moderate)
[laiyuan] => 血小板功能检测可以指导近期接受P2Y12抑制剂治疗的患者决定心脏手术的时机。(证据级别:中)
[znzldj] => B
[_inputtime] => 1704957869
[_updatetime] => 1704957869
[_nrjc] =>
[_nrsh] =>
)
推荐意见
血小板功能检测可以指导近期接受P2Y12抑制剂治疗的患者决定心脏手术的时机。(证据级别:中)
Platelet function testing may be considered to guide the decision on the timing of cardiac surgery in patients who have recently received P2Y12 inhibitors.(Evidence level: moderate)
证据评价方法:GRADE
指南质量等级:B
年份:2023
国家:the European Society of Anaesthesiology and Intens
Array
(
[id] => 1300
[catid] => 297
[title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1300.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:24:29
[updatetime] => 2024-01-11 15:24:29
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => Bridging oral antiplatelet therapy with LMWH is not recommended.(Evidence level:high;Recommendation grade: strong)
[laiyuan] => 不推荐口服低分子肝素进行桥接抗血小板治疗。(证据级别:高;推荐强度:强推荐)
[znzldj] => B
[_inputtime] => 1704957869
[_updatetime] => 1704957869
[_nrjc] =>
[_nrsh] =>
)
推荐意见
不推荐口服低分子肝素进行桥接抗血小板治疗。(证据级别:高;推荐强度:强推荐)
Bridging oral antiplatelet therapy with LMWH is not recommended.(Evidence level:high;Recommendation grade: strong)
证据评价方法:GRADE
指南质量等级:B
年份:2023
国家:the European Society of Anaesthesiology and Intens
Array
(
[id] => 1301
[catid] => 297
[title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1301.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:24:29
[updatetime] => 2024-01-11 15:24:29
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => We suggest that aspirin or P2Y12 inhibitors may be administered in the early postoperative period without increasing the risk of postoperative bleeding.(Evidence level: low;Recommendation grade: weak)
[laiyuan] => 我们建议在术后早期使用阿司匹林或P2Y12抑制剂,不会增加术后出血的风险。(证据级别:低;推荐强度:弱推荐)
[znzldj] => B
[_inputtime] => 1704957869
[_updatetime] => 1704957869
[_nrjc] =>
[_nrsh] =>
)
推荐意见
我们建议在术后早期使用阿司匹林或P2Y12抑制剂,不会增加术后出血的风险。(证据级别:低;推荐强度:弱推荐)
We suggest that aspirin or P2Y12 inhibitors may be administered in the early postoperative period without increasing the risk of postoperative bleeding.(Evidence level: low;Recommendation grade: weak)
证据评价方法:GRADE
指南质量等级:B
年份:2023
国家:the European Society of Anaesthesiology and Intens